Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections

scientific article published on 22 February 2016

Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.02597-15
P932PMC publication ID4862545
P698PubMed publication ID26902764

P50authorFrederic LaurentQ64140611
Florent ValourQ83509245
Tristan FerryQ63379749
Florence AderQ63777339
P2093author name stringSylvain Goutelle
Sébastien Lustig
Christian Chidiac
Marie-Claude Gagnieu
Sandrine Roux
P2860cites workDaptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditisQ33576260
Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of AmericaQ34316506
In vivo pharmacodynamic activity of daptomycinQ35005549
Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysisQ36558512
Population pharmacokinetics of daptomycinQ36670451
Daptomycin: a review 4 years after first approvalQ36972980
Fundamentals of population pharmacokinetic modelling: validation methodsQ38026590
Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.Q40118820
Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infectionsQ43106836
Clinical and pharmacokinetic considerations for the use of daptomycin in patients with Staphylococcus aureus bacteraemia and severe renal impairmentQ44753682
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine valuesQ45119840
Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections.Q45873401
The importance of modeling interoccasion variability in population pharmacokinetic analysesQ46317518
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
P304page(s)3148-3151
P577publication date2016-02-22
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titlePharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections
P478volume60